Latest Brain tumor Stories
MarketResearchReports.Biz include new market research report "Glioblastoma Multiforme Therapeutics In Asia-Pacific Markets To 2020 - Novel Therapeutic Approaches Target High Unmet Need In
Japanese Society of Neuro-Oncology calls for rapid approval by the Japanese Ministry of Health and Welfare (MHLW) ST. HELIER, Jersey, Aug.
VAL-083 Phase I/II VAL-083 clinical trial advances to 50mg/m(2) cohort VANCOUVER, British Columbia and MENLO PARK, Calif., Aug.
A smart technology which involves smuggling gold nanoparticle into brain cancer cells has proven highly effective in lab-based tests
SAN FRANCISCO, Aug.
Trial Progressing On Track; BETHESDA, Md., Aug.
Recent studies have shown that transplanting induced pluripotent stem cell-derived neural stem cells (iPS-NSCs) can promote functional recovery after spinal cord injury in rodents and non-human primates.
NuvOx Pharma, a Tucson based biotechnology company, began a Phase Ib clinical trial of its new drug NVX-108 in patients with glioblastoma, a deadly form of brain cancer. Tucson,
POINT ROBERTS, Wash. and NEW YORK, Aug.
New research at Washington University School of Medicine in St. Louis helps explain why brain tumors occur more often in males and frequently are more harmful than similar tumors in females.
- Emitting flashes of light; glittering.